glioma

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Navigating the Clinical Research Process for Glioma

Not yet recruiting
  • Glioma
    • San Francisco, California
      Power Life Sciences
    Jul 14, 2023

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1429 more
    Aug 17, 2022

    Glioma Trial in United States (ONC201)

    Active, not recruiting
    • Glioma
    • San Francisco, California
    • +8 more
    Jul 14, 2022

    Glioma Trial in United States (ONC201)

    No longer available
    • Glioma
    • San Francisco, California
    • +9 more
    May 19, 2022

    Glioma Trial in United States (AG881)

    Active, not recruiting
    • Glioma
    • Los Angeles, California
    • +8 more
    May 16, 2022

    Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Phoenix, San Francisco (Niraparib, Radiation therapy)

    Recruiting
    • Glioblastoma
    • +5 more
    • Phoenix, Arizona
    • +1 more
    Dec 7, 2021

    Gliogene: Brain Tumor Linkage Study

    Active, not recruiting
    • Brain Tumor
    • Glioma
    • Questionnaire
    • San Francisco, California
    • +14 more
    Dec 29, 2020

    68Ga-citrate PET/MR Imaging for Glioma

    Terminated
    • Glioma
    • 68Ga-citrate PET/MR
    • San Francisco, California
      University of California, San Francisco
    Apr 29, 2020

    Glioma Trial in San Francisco (Device: iPad)

    Terminated
    • Glioma
    • Device: iPad
    • San Francisco, California
      University of California, San Francisco
    Jan 14, 2020

    Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of

    Terminated
    • Glioblastoma Multiforme
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • +3 more
    • Los Angeles, California
    • +4 more
    Nov 12, 2019

    Glioma Trial in San Francisco (5-Aminolevuline Acid (ALA))

    Terminated
    • Glioma
    • 5-Aminolevuline Acid (ALA)
    • San Francisco, California
      UCSF Department of Neurosurgery
    May 7, 2019

    Glioma Trial in Germany, Spain, United States (LY2157299, Radiation, Temozolomide)

    Completed
    • Glioma
    • La Jolla, California
    • +9 more
    Feb 15, 2017

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in United States (VAL-083 (Dianhydrogalactitol))

    Completed
    • Glioma
    • +4 more
    • VAL-083 (Dianhydrogalactitol)
    • San Francisco, California
    • +4 more
    Jan 19, 2017

    Glioma Trial in United States (capecitabine [Xeloda])

    Completed
    • Glioma
    • capecitabine [Xeloda]
    • San Francisco, California
    • +8 more
    Oct 25, 2016